Sector ratings Laboratorios Farmaceuticos Rovi, S.A.

Stocks

Real-time Estimate Tradegate 07:20:36 2026-08-13 am EDT			5-day change	1st Jan Change
58.40 ^EUR	+1.04%		-0.43%	-8.11%

Jul. 23	Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026
Jul. 23	Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
LABORATORIOS FARMACEUTICOS ROVI, S.A.	3.41B		BBB
ELI LILLY AND COMPANY	1,088B		A
JOHNSON & JOHNSON	629B	-	BBB	-	-
ABBVIE INC.	440B	-	AA	-	-
ROCHE HOLDING AG	359B		AA
NOVARTIS AG	291B		AAA
ASTRAZENECA PLC	245B		A
AMGEN INC.	225B		A
NOVO NORDISK A/S	204B		A
GILEAD SCIENCES, INC.	168B		AA
PFIZER INC.	150B		A
VERTEX PHARMACEUTICALS INCORPORATED	133B		AA
BRISTOL-MYERS SQUIBB COMPANY	130B		A
SANOFI	104B		AA
GSK PLC	101B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	74.22B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	55.77B		AA
BAYER AG	54.43B		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	53.12B		AA
HALEON PLC	42.82B		AA
Average	227.59B		AA
Weighted average by Cap.			AA